DNA methylation, a form of chemical modification of DNA, can effect the genetic expression without changing the DNA sequence. DNA methylation plays an important role in the maintenance of the function of normal cells, inactivation of X chromosome in female, stabilization of genome structure, embryonic development, development and progression of certain diseases such as tumer. EM-seq (Enzymatic Methyl-sequencing) is a powerful technique that has been developed to study DNA methylation patterns with high precision and sensitivity.
Service you may intersted in
For more details, please refer to the following articles:
Enzymatic Methyl-seq mechanism of action and workflow. (Romualdas et al., 2021)
Enzymes involved in the EM-seq to detect 5-mC and 5-hmC (Romualdas et al., 2021)
Quality control: The data generated by EM-seq is both large and complex, and therefore requires a sophisticated data analysis method. Quality control is the first and most important step in the pipeline. The process involves assessing the quality of DNA methylation, checking for any existing contaminants, and ensuring that the data is suitable for further analysis. FastQC can be used to check for length distribution, GC content, and the presence of suitable sequences. Low-quality reads and those with contamination are removed using specific programs such as Trimmomatic.
Methylation Calling: After quality control, the information is recorded onto a reference genome. This recording process requires powerful bioinformatics algorithms and significant computational resources. Once the information recording is complete, methylation response could be made. Methylation response means to distinguish the methylated and unmethylated cytosines based on specific patterns and signals in the sequencing data. Software such as Bismark could be used to identify methylated cytosine sites. The level of methylation at each site can be quantified and is calculated as the ratio of methylation at a particular cytosine site to the total number of methylations at that site.
Differential methylation analysis: Differential methylation analysis is then performed to compare methylation patterns under experimental conditions. This can help in identifying regions of the genome where methylation changes are associated with specific biological processes or diseases. Plenty of tools could be used to analyse methylation, which detects the methylation levels to identify regions that are differentially methylated.
Visualization: Tools like Integrative Genomics Viewer (IGV) could be used to analyse the methylation data of the genome. This allows researchers to analyse the methylation patterns based on genomic structure, including genes, exons, introns, and other genomic features. Visualization of differential methylation levels at specific site can provide deeper insights into the data, and therefore produce insightful interpretation.
High resolution: EM-seq can provide single-base resolution of DNA methylation, which allows for a more precise identification of methylation sites on the DNA. For example, EM-seq could be used to precisely detect methylated cytosines when studying gene-regulatory substance, and to gain insights into how methylation affect gene expression even at low DNA concentration.
Reduced DNA damage: Compared to traditional BS-seq, EM-seq employs a milder enzymatic digestion method. While bisulfite treatment in BS-seq could cause DNA damage, the enzymatic digestion process in EM-seq reduce this damage, resulting in DNA with a higher quality for sequencing. EM-seq better protects the integrity of the DNA, resulting in higher accuracy and more reliable detection of methylation sites.
Compatibility with high-throughput sequencing: EM-seq enables the analysis of a large number of samples within a relatively short time. EM-seq, with the characteristic of high-throughput, is crucial for genome-wide methylation studies, where thousands or even millions of methylation sites need to be analyzed of massive samples. For instance, in large-scale cancer epigenetics studies, researchers can quickly analyse a cohort of tumor and normal tissue samples to identify methylation differences associated with the disease by introducing EM-seq during the detection process.
Improved sensitivity and specificity: The enzymatic reactions in EM-seq can offer more accurate identification of methylated and unmethylated cytosines. The specificity of the enzymatic steps and the subsequent analysis can lead to a reduction in false-positive and false-negative results. EM-seq with improved sensitivity and specificity is beneficial for studies that require a high degree of precision, such as those aiming to identify rare methylation events or small methylation changes that could have significant biological implications.
Complex enzymatic reactions: The dependence of enzymatic processes in EM-seq means that the technique is more sensitive to enzyme performance and reaction conditions. The enzymes used in the process need to be carefully optimized in terms of temperature, pH, and reaction times. Any change of the conditions, no matter how small it is, could have a great influence of the accuracy and reproducibility of the results. For example, if the temperature is not properly controlled during the methylation-protection step, it could lead to incomplete protection of methylated cytosines and incorrect methylation detection.
Higher cost: The use of specific enzymes and the need for high-quality reagents for EM-seq could make it a relatively expensive technique. Additionally, the high-throughput sequencing also increases the cost. The expense may limit the usage of EM-seq in some laboratories with budget constraints, especially when large-scale studies involving numerous samples are planned.
Bioinformatics challenges: Analyzing EM-seq data requires specialized bioinformatics tools and professional knowledge. The data analysis process is more complex compared to some other sequencing methods due to the specificity of the enzymatic modifications and the need to accurately detect methylation sites. Interpreting the results also requires a good understanding of biological knowledge, any error in the bioinformatics analysis could lead to wrong identification of methylation patterns and therefore draw an incorrect conclusion.
In conclusion, EM-seq represents a significant milestone in the field of the detection of DNA methylation. Its enzymatic-based approach offers a more accurate, less damaging, and potentially more cost-effective alternative to traditional BS-seq for analyzing DNA methylation patterns. With wide applications in developmental biology, EM-seq is considered to continue making more contributions to our understanding of DNA methylation. However, continuous efforts are also needed to address the technical challenges and improve the data analysis methods to fully realize the potential of this powerful technique.
Reference
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.